{"id":"https://openalex.org/W2044374397","doi":"https://doi.org/10.1111/dom.12402","title":"Is insulin the most effective injectable antihyperglycaemic therapy?","display_name":"Is insulin the most effective injectable antihyperglycaemic therapy?","publication_year":2014,"publication_date":"2014-10-17","ids":{"openalex":"https://openalex.org/W2044374397","doi":"https://doi.org/10.1111/dom.12402","mag":"2044374397","pmid":"https://pubmed.ncbi.nlm.nih.gov/25323312"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12402","doi":"https://doi.org/10.1111/dom.12402","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12402","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12402","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12402","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040182038","display_name":"John B. Buse","orcid":"https://orcid.org/0000-0002-9723-3876","observed_orcids":["https://orcid.org/0000-0002-9723-3876","https://orcid.org/0000-0001-6894-4110"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1333535994","display_name":"University of North Carolina Health Care","ror":"https://ror.org/00qz24g20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1333535994"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"J. B. Buse","raw_affiliation_strings":["University of North Carolina School of Medicine Medicine/Endocrinology  Chapel Hill NC USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina School of Medicine Medicine/Endocrinology  Chapel Hill NC USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1333535994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001347850","display_name":"Anne L. Peters","orcid":"https://orcid.org/0000-0003-0520-0776","observed_orcids":["https://orcid.org/0000-0003-0520-0776"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Peters","raw_affiliation_strings":["Keck School of Medicine University of Southern California  Los Angeles CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keck School of Medicine University of Southern California  Los Angeles CA USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082184915","display_name":"David L Russell-Jones","orcid":"https://orcid.org/0000-0002-9490-2480","observed_orcids":["https://orcid.org/0000-0002-9490-2480"]},"institutions":[{"id":"https://openalex.org/I2799660017","display_name":"Royal Surrey County Hospital","ror":"https://ror.org/02w7x5c08","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799660017","https://openalex.org/I4210146582"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. Russell\u2010Jones","raw_affiliation_strings":["Endocrinology and Metabolism, Royal Surrey County Hospital  Guildford UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology and Metabolism, Royal Surrey County Hospital  Guildford UK","institution_ids":["https://openalex.org/I2799660017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060781511","display_name":"Sabina Furber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268700","display_name":"Novo Nordisk Canada (Canada)","ror":"https://ror.org/01th56526","country_code":"CA","type":"company","lineage":["https://openalex.org/I4405268700"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S. Furber","raw_affiliation_strings":["Novo Nordisk Pharmaceuticals  Sydney Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Pharmaceuticals  Sydney Australia","institution_ids":["https://openalex.org/I4405268700"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026337749","display_name":"Morten Donsmark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"M. Donsmark","raw_affiliation_strings":["Novo Nordisk A/S  S\u00f8borg Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S  S\u00f8borg Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089249621","display_name":"J. Han","orcid":"https://orcid.org/0009-0003-7384-7755","observed_orcids":["https://orcid.org/0009-0003-7384-7755"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Han","raw_affiliation_strings":["Amylin Pharmaceuticals LLC  San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals LLC  San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018272606","display_name":"Leigh MacConell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. MacConell","raw_affiliation_strings":["Amylin Pharmaceuticals LLC  San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals LLC  San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062921481","display_name":"David G. Maggs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Maggs","raw_affiliation_strings":["Amylin Pharmaceuticals LLC  San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals LLC  San Diego CA USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109335776","display_name":"Micha\u00ebla Diamant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M. Diamant","raw_affiliation_strings":["VU University Medical Center Diabetes Center, Department of Internal Medicine  Amsterdam The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU University Medical Center Diabetes Center, Department of Internal Medicine  Amsterdam The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5040182038"],"corresponding_institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1333535994"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":{"value":5380,"currency":"USD","value_usd":5380},"fwci":2.6158,"has_fulltext":true,"cited_by_count":32,"citation_normalized_percentile":{"value":0.89421,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"17","issue":"2","first_page":"145","last_page":"151"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9150000214576721},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.9150000214576721},{"id":"https://openalex.org/keywords/exenatide-once-weekly","display_name":"exenatide once weekly","score":0.8820000290870667},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":1.0},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9240000247955322},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7950000166893005},{"id":"https://openalex.org/keywords/hba1c-reduction","display_name":"HbA1c reduction","score":0.9070000052452087},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.722000002861023},{"id":"https://openalex.org/keywords/weight-change","display_name":"weight change","score":0.7070000171661377},{"id":"https://openalex.org/keywords/insulin-dose","display_name":"insulin dose","score":0.6710000038146973},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.8600000143051147}],"concepts":[{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.8893254995346069},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.8670803308486938},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8364914655685425},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.7995212078094482},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6662120223045349},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5908781290054321},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5243737697601318},{"id":"https://openalex.org/C68443243","wikidata":"https://www.wikidata.org/wiki/Q2786686","display_name":"Quartile","level":3,"score":0.5123578310012817},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.4531167447566986},{"id":"https://openalex.org/C2775927303","wikidata":"https://www.wikidata.org/wiki/Q16252338","display_name":"Insulin degludec","level":5,"score":0.42077717185020447},{"id":"https://openalex.org/C2776442814","wikidata":"https://www.wikidata.org/wiki/Q6659956","display_name":"Lixisenatide","level":5,"score":0.411538302898407},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37638604640960693},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.2152118980884552},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.09426900744438171}],"mesh":[{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005215","descriptor_name":"Fasting","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/dom.12402","doi":"https://doi.org/10.1111/dom.12402","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12402","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12402","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:25323312","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25323312","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Comparative Study"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/d559c594-38f4-4712-ad74-e9ee6a82ead8","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/d559c594-38f4-4712-ad74-e9ee6a82ead8","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Buse, J B, Peters, A, Russell-Jones, D, Furber, S, Donsmark, M, Han, J, MacConell, L, Maggs, D & Diamant, M 2015, 'Is insulin the most effective injectable antihyperglycaemic therapy?', Diabetes, Obesity and Metabolism, vol. 17, no. 2, pp. 145-151. https://doi.org/10.1111/dom.12402","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/1308bb19-9da8-4480-8137-f823dc993753","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/1308bb19-9da8-4480-8137-f823dc993753","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes, Obesity and Metabolism, 17(2), 145 - 151. Wiley-Blackwell","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1111/dom.12402","doi":"https://doi.org/10.1111/dom.12402","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12402","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12402","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320309487","display_name":"Osiris Therapeutics","ror":"https://ror.org/03r8s5x58"},{"id":"https://openalex.org/F4320314793","display_name":"Intarcia Therapeutics","ror":"https://ror.org/00s0pgz81"},{"id":"https://openalex.org/F4320315147","display_name":"Orexigen Therapeutics","ror":"https://ror.org/04cnvsy93"},{"id":"https://openalex.org/F4320315641","display_name":"Halozyme","ror":"https://ror.org/001x5ea44"},{"id":"https://openalex.org/F4320315955","display_name":"Quest Diagnostics","ror":"https://ror.org/010g9bb70"},{"id":"https://openalex.org/F4320316051","display_name":"Dexcom","ror":"https://ror.org/03ra42c27"},{"id":"https://openalex.org/F4320321014","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320333256","display_name":"Abbott Diabetes Care","ror":"https://ror.org/03vb88585"}],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2044374397.pdf"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2026902135","https://openalex.org/W2046319600","https://openalex.org/W2057002261","https://openalex.org/W2111876001","https://openalex.org/W2122643907","https://openalex.org/W2126781806","https://openalex.org/W2127521907","https://openalex.org/W2137352234","https://openalex.org/W2139485303","https://openalex.org/W2139925874","https://openalex.org/W2163457223"],"related_works":["https://openalex.org/W2528138059","https://openalex.org/W2141132900","https://openalex.org/W2138897693","https://openalex.org/W3121084704","https://openalex.org/W4312211810","https://openalex.org/W2079160676","https://openalex.org/W2059678666","https://openalex.org/W2765093610","https://openalex.org/W2604317643","https://openalex.org/W2527920149"],"abstract_inverted_index":{"AIMS:":[0],"The":[1],"recent":[2],"type":[3,280],"2":[4,281],"diabetes":[5],"American":[6],"Diabetes":[7,14],"Association/European":[8],"Association":[9],"for":[10,121,153,201],"the":[11,21,145,197,250],"Study":[12],"of":[13,93,147,159,186,262],"(ADA/EASD)":[15],"position":[16],"statement":[17],"suggested":[18],"insulin":[19,75,129,278],"is":[20,31,287],"most":[22],"effective":[23],"glucose-lowering":[24],"therapy,":[25],"especially":[26],"when":[27,284],"glycated":[28],"haemoglobin":[29],"(HbA1c)":[30],"very":[32,288],"high.":[33],"However,":[34],"randomized":[35],"studies":[36],"comparing":[37],"glucagon-like":[38],"peptide-1":[39],"receptor":[40],"agonists":[41],"(GLP-1RAs)":[42],"exenatide":[43,61,106,270],"once-weekly":[44],"[OW;":[45],"DURATION-3":[46,94],"(Diabetes":[47],"therapy":[48],"Utilization:":[49],"Researching":[50],"changes":[51,98],"in":[52,72,99,123,155,168,170,179,279],"A1c,":[53],"weight,":[54,127,228],"and":[55,63,70,95,103,110,128,131,184,269],"other":[56],"factors":[57],"Through":[58],"Intervention":[59],"with":[60,74,81,105,196,214,218,244,249,258],"ONce-Weekly)]":[62],"liraglutide":[64,109,268],"once-daily":[65],"[OD;":[66],"LEAD-5":[67,96],"(Liraglutide":[68],"Effect":[69],"Action":[71],"Diabetes)]":[73],"glargine":[76,200,226],"documented":[77],"greater":[78,195,213],"HbA1c":[79,85,114,135,139,149,171,173,182,189,204,247,286],"reduction":[80,208,248],"GLP-1RAs,":[82],"from":[83],"baseline":[84,113,138,148,203,232,263,285],"\u223c8.3%":[86],"(67":[87],"mmol/mol).":[88],"This":[89,265],"post":[90],"hoc":[91],"analysis":[92,143,158],"examined":[97],"HbA1c,":[100,124],"fasting":[101,125],"glucose":[102,207],"weight":[104],"OW":[107,271],"or":[108,193,211],"glargine,":[111],"by":[112,137],"quartile.":[115,140],"METHODS:":[116],"Descriptive":[117],"statistics":[118],"were":[119,191,236],"provided":[120],"change":[122,154,169],"glucose,":[126],"dose,":[130],"subjects":[132,187,224],"(%)":[133],"achieving":[134],"<7.0%,":[136,190],"Inferential":[141],"statistical":[142],"on":[144],"effect":[146],"quartile":[150],"was":[151,163,209],"performed":[152],"HbA1c.":[156,233,264],"An":[157],"covariance":[160],"(ANCOVA)":[161],"model":[162],"used":[164],"to":[165,256,276],"evaluate":[166],"similarity":[167],"across":[172,221],"quartiles.":[174,205],"RESULTS:":[175],"At":[176],"26":[177],"weeks,":[178],"both":[180,219],"studies,":[181],"reduction,":[183],"proportion":[185],"reaching":[188],"similar":[192,210],"numerically":[194,212],"GLP-1RAs":[198,220,251],"than":[199],"all":[202,222],"Fasting":[206],"glargine.":[215],"Weight":[216],"decreased":[217],"quartiles;":[223],"taking":[225],"gained":[227],"more":[229,242],"at":[230,253],"higher":[231],"Adverse":[234],"events":[235,240],"uncommon":[237],"although":[238],"gastrointestinal":[239],"occurred":[241],"frequently":[243],"GLP-1RAs.":[245],"CONCLUSIONS:":[246],"appears":[252],"least":[254],"equivalent":[255],"that":[257,267],"basal":[259,277],"insulin,":[260],"irrespective":[261],"suggests":[266],"may":[272],"be":[273],"appropriate":[274],"alternatives":[275],"diabetes,":[282],"including":[283],"high":[289],"(\u22659.0%).":[290]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}